Free Submission Public Relations &
Deutsch English

Global Epigenetics Market 2014-2018

C&M: Global industry for epigenetics to be driven by steadily growing aging population worldwide

Print article Print article
2014-01-09 02:07:02 - Global Epigenetics Market 2014-2018 - a new market research report on

The Global Epigenetics market is forecast to grow at a CAGR of 28.79 percent for the period 2013-2018. Several driving factors and trends will contribute to this growth.

Along with oncology indications, epigenetic drugs also find application in non-oncology indications such as inflammatory diseases, autoimmune diseases, neurodegenerative disorders, and personalized medicine. These are some of the high growth and emerging areas that are expected to drive the Global Epigenetics market in the future. Current treatments for chronic and degenerative disorders are in many cases inadequate or very expensive. Epigenetic drugs are attractive options for treating such disorders because they manipulate the processes that maintain cells in an abnormal transcriptional state.

Click for report details: ..

Browse all Healthcare and Medical Market Research



Reports ..

Browse all Healthcare and Medical Company Profile Reports ..

Browse all Latest Market Research Reports ..

About Us is a leading online business information aggregator with over 300,000 market reports and company profiles available to our clients. Our extensive range of reports are sourced from the leading publishers of business information and provide clients with the widest range of information available. In terms of company profiles,’s online database allows clients access to market and corporate information to over 100,000 different companies. We provide clients with a fully indexed database of information where clients can find specific market reports on their niche industry sectors of interest.

Mike King
Phone: London: +44 (0) 203 086 8600

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News


Terms & Conditions | Privacy | About us | Contact